Rabies treatment safety study in kids halted early
NCT ID NCT05382650
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to check the safety of a rabies immune globulin shot (HyperRAB) in children who were treated after an animal bite. It included 35 kids aged 17 and under across several emergency rooms. The study was stopped early, so results are limited, but the goal was to see if the shot caused any side effects within a few days to a month.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRICS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Houston Methodist
Houston, Texas, 77030, United States
-
Texas Children's Hospital
Houston, Texas, 77030, United States